Provision of: Amyloidosis Networked Model of Care
A Contract Award Notice
by NHS ENGLAND
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £1M
- Sector
- HEALTH
- Published
- 27 Feb 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
South West England:
1 buyer
- NHS England Leeds
2 suppliers
Description
NHS England, Highly Specialised Services (referred to as the Commissioner) is awarding to suitably qualified and experienced providers for the Provision of Amyloidosis Networked Model of Care services, following a Competitive Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process.Amyloidosis is the name for a group of rare, serious conditions caused by a build-up of an abnormal protein, called amyloid, in organs and tissues throughout the body. The build-up of amyloid proteins (deposits) can make it difficult for the organs and tissues to work properly.The key objectives of the Competitive Process was to commission a networked model of care for Amyloidosis services to establish four regional centres under this initial process. This is to ensure a good level of access in place that is able to meet the expected demand for the service. The regional centres are proposed to be in the:• Lot 2 - Midlands• Lot 3 - North West
Lot Division
| 1 | South West NHS England, Highly Specialised Services (referred to as the Commissioner) is not awarding to any provider for the Lot (1) in the South West.Amyloidosis is the name for a group of rare, serious conditions caused by a build-up of an abnormal protein, called amyloid, in organs and tissues throughout the body. … This is to ensure a good level of access in place that is able to meet the expected demand for the service. |
| 2 | Midlands NHS England, Highly Specialised Services (referred to as the Commissioner) is awarding to suitably qualified and experienced provider for the Provision of Amyloidosis Networked Model of Care services, following a Competitive Process. … The build-up of amyloid proteins (deposits) can make it difficult for the organs and tissues to work properly.The key objectives of the Competitive Process was to commission a networked model of care for Amyloidosis services to establish regional centres under this initial process. This is to ensure a good level of access in place that is able to meet the expected demand for the service.The regional centre to be awarded is for:• Lot 2 - Midlands |
| 3 | North West NHS England, Highly Specialised Services (referred to as the Commissioner) is awarding to suitably qualified and experienced provider for the Provision of Amyloidosis Networked Model of Care services, following a Competitive Process. … This is to ensure a good level of access in place that is able to meet the expected demand for the service.The regional centre is to be in the:• Lot 3 - North West |
| 4 | North East and Yorkshire NHS England, Highly Specialised Services (referred to as the Commissioner) is not awarding under Lot 4 (North East and Yorkshire). As no bids were received. |
Award Detail
| 1 | University Hospitals Birmingham NHS Trust (Birmingham)
|
| 2 | Clatterbridge Cancer Centre NHS Trust (Wirral)
|
Award Criteria
| Quality | 100 |
| Price | 0 |
CPV Codes
- 85000000 - Health and social work services
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health CareServices (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by Tuesday 11 March 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.’ Representations should be sent to anna.salt@nhs.net. The award decision-makers is NHS England National Commissioning Group (NCG); - The Key Criteria used for the award:Quality & innovation: 35%Value: Pass or FailIntegration, Collaboration& Service Sustainability: 26%Improving Access,Reducing Health Inequalities and FacilitatingChoice: 24%Social Value: 15%The rationale for choosing the provider(s) were based on them being the highest scoring bidders, which was approved by NHS England governance following a comprehensive evaluation process.
Reference
- ocds-h6vhtk-049d59
- FTS 007449-2025